[Ip-health] WHO EB146: Statement of Knowledge Ecology International on the Global strategy and plan of action on public health, innovation and intellectual property

Thiru Balasubramaniam thiru at keionline.org
Thu Feb 6 22:44:10 PST 2020


On Thursday evening, 6 February 2020, Knowledge Ecology International (KEI)
delivered the following statement on WHO’s Global strategy and plan of
action on public health, innovation and intellectual property.

We request WHO’s Global Observatory on Health Research and Development to
create a database to collect information on the research and development
costs directly associated with clinical trials used to support the
registration of medicines, vaccines and cell and gene-therapies. This would
align the Observatory’s activities with the mandate of the WHO transparency

We commend the policy recommendation emanating from the Report on Cancer
(published on February 4th, 2020 on World Cancer Day) which called on
countries and health systems to report “the costs of research, development,
and production, including any public sources of funding of cancer

We request the Director-General to conduct a feasibility study to examine
models of different possible means of de-linking research and development
costs from product prices. In light of the rise of catastrophic health
expenditures that drain health budgets, WHO will never achieve universal
health coverage without the delinkage of R&D costs from the prices of
drugs, vaccines and other health technologies.

Thank you Dr. Nakatani.

Thiru Balasubramaniam
Geneva Representative
Knowledge Ecology International
41 22 791 6727
thiru at keionline.org

More information about the Ip-health mailing list